Your browser doesn't support javascript.
loading
Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia.
Cochran, Jeffrey M; Fang, Hui; Le Gallo, Christophe; Peters-Strickland, Timothy; Lindenmayer, Jean-Pierre; Reuteman-Fowler, J Corey.
Afiliación
  • Cochran JM; Medical & Real World Data Analytics, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
  • Fang H; Biostatistics, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
  • Le Gallo C; Clinical Programming, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
  • Peters-Strickland T; PPD, Inc., Wilmington, NC, USA.
  • Lindenmayer JP; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
  • Reuteman-Fowler JC; Global Clinical Development, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Patient Prefer Adherence ; 16: 1805-1817, 2022.
Article en En | MEDLINE | ID: mdl-35923658
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Patient Prefer Adherence Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Patient Prefer Adherence Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos